Presentation Transcripts
Latest Update : Dec.9, 2022
Back to Financial Results (FY3/2023)
Investor Meeting Presentation for 2Q FY 3/2023 held on November 2, 2022
- Cover
- Today's Agenda
- Financial Results
- Summary of Consolidated Business Results for 2Q
- Summary of Consolidated Business Results for 1H
- Net Sales, Operating Income/ Margin
- 2Q Actual: Differences from the Forecast as of August
- Machined Components
- Electronic Devices & Components
- MITSUMI Business
- U-Shin Business
- Profit Attributable to Owners of the Parent / EPS
- Inventory
- Net Interest-bearing Debt / Free Cash Flow
- Forecast for Fiscal Year Ending March 31, 2023
- Forecast for Business Segment
- Business Update & Management Strategy
- 1H Results
- Acquired Drivers to Accelerate Organic Growth
- Products to Solve Social Issues Drive Growth
- Key Points of FY3/23 Forecast
- Machined Components
- Electronic Devices and Components
- MITSUMI Business (1)
- Further Growth of Analog Semiconductors
- [Reference] Analog Semi. Order Volume Trend
- MITSUMI Business (2)
- Further Growth of Connectors
- Direction of Connector Business
- U-Shin Business
- Access Product Share No.1 Strategy
- Estimate for Next Fiscal Year
- Progress on Announced M&As
- To Issue Green Bonds
- Dividends
- ESG Topics
- Forward-looking Statements
- Reference
Download
I will explain the situation in each segment.
First, in regard to bearings, CAGR has increased quite a bit since the Shanghai lockdown, coming to 11%, but as I explained, there has been a slight lull in the third quarter. This may be in part a reaction to companies holding safety inventory in response to supply chain and semiconductor shortage issues.
However, as I always say, miniature and small-diameter bearings will most definitely continue to grow in the future, so I am not the slightest bit worried.
In the aircraft components business, single-aisle aircraft production has currently recovered, driven by Airbus. It looks like it will take a little more time for American aircraft, but the aircraft-related business has grown and is now making up for others. In addition, sales of products for medical devices had slowed due to COVID-19, but they have since grown beyond that, so in the month of September alone, we were actually able to record 1.0 billion yen in operating income.
Moreover, while being impacted by COVID-19, we switched from push-type to pull-type production, so we are now able to maintain zero delivery delays as production has ramped up. I think this is a very good development.
In the machined components segment, I believe we can reach full-year operating income of 50.0 billion yen thanks in part to the tailwind provided by the exchange rate.
Previous
22page (total 46pages)
You need Adobe Reader® to view these documents. Click on Adobe Reader icon on the left to download the software from the Adobe Systems website.
It ends about main text.
